<p>Specialty chemical company Anupam Rasayan has filed preliminary papers with markets regulator Sebi to raise Rs 760 crore through an initial public offering.</p>.<p>Proceeds of the issue would be used mainly for repayment of debt, the company said in the draft red herring prospectus (DRHP).</p>.<p>Surat-based company has decided to reserve a portion for its employees and may consider a discount for eligible staff.</p>.<p>Anupam Rasayan commenced operations in 1984 with conventional products and now it makes speciality chemicals that involve multi-step synthesis and complex chemistries.</p>.<p>It has six multi-purpose manufacturing facilities based in Gujarat with a combined aggregate installed capacity of around 23,396 metric tonne, of which 6,726 metric tonne was added in March 2020.</p>.<p>The company mainly caters to the agrochemical, personal care and pharmaceutical sectors, which accounted for over 95 per cent of its revenues in 2019-20. Its clients include Syngenta Asia Pacific, Sumitomo Chemical Company and UPL Limited.</p>.<p>Axis Capital, Ambit Private, IIFL Securities and JM Financial have been appointed as merchant bankers for the issue. </p>
<p>Specialty chemical company Anupam Rasayan has filed preliminary papers with markets regulator Sebi to raise Rs 760 crore through an initial public offering.</p>.<p>Proceeds of the issue would be used mainly for repayment of debt, the company said in the draft red herring prospectus (DRHP).</p>.<p>Surat-based company has decided to reserve a portion for its employees and may consider a discount for eligible staff.</p>.<p>Anupam Rasayan commenced operations in 1984 with conventional products and now it makes speciality chemicals that involve multi-step synthesis and complex chemistries.</p>.<p>It has six multi-purpose manufacturing facilities based in Gujarat with a combined aggregate installed capacity of around 23,396 metric tonne, of which 6,726 metric tonne was added in March 2020.</p>.<p>The company mainly caters to the agrochemical, personal care and pharmaceutical sectors, which accounted for over 95 per cent of its revenues in 2019-20. Its clients include Syngenta Asia Pacific, Sumitomo Chemical Company and UPL Limited.</p>.<p>Axis Capital, Ambit Private, IIFL Securities and JM Financial have been appointed as merchant bankers for the issue. </p>